Short-course fluoroquinolone treatment is as effective as the conventional 7-day course for acute exacerbations of chronic ...

More than 80 million people in Europe are affected, and many more are undiagnosed, with primary care practitioners ill-prepared to identify the conditions.

According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...

People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...

New Partnership with Leonard Nimoy’s Daughter Aims to Raise COPD Awareness ...

A 6-minute walk of less than 350 meters tripled the mortality risk, whereas chronic kidney disease (CKD) independently ...

as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD). Nucala stands out as the only approved biologic that has been ...

Sly Stone dies at the age of 82 and his death highlights the dangers of COPD a chronic lung disease linked to smoking and air ...

Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL. The FDA has approved GSK’s Nucala ...